A little light on the Mayo: justifying reversal of the Federal Circuit's Association for Molecular Pathology decision
- PMID: 24654292
Item in Clipboard
A little light on the Mayo: justifying reversal of the Federal Circuit's Association for Molecular Pathology decision
Seton Hall Law Rev.
2014.
No abstract available
Similar articles
-
DNA patent decision leaves questions for diagnostics.Nat Rev Drug Discov. 2011 Aug 31;10(9):650-1. doi: 10.1038/nrd3548. Nat Rev Drug Discov. 2011. PMID: 21878971 No abstract available.
-
The Federal Circuit's decision in Myriad: isolated DNA molecules are patentable subject matter.Am Univ Law Rev. 2011;61(2):443-56. Am Univ Law Rev. 2011. PMID: 25335196 No abstract available.
-
Take off your genes and let the doctor have a look: why the Mayo and Myriad decisions have invalidated method claims for genetic diagnostic testing.Am Univ Law Rev. 2013;63(1):173-217. Am Univ Law Rev. 2013. PMID: 25335200
-
Intellectual property and regulation of molecular pathology tests.Cancer J. 2014 Jan-Feb;20(1):85-90. doi: 10.1097/PPO.0000000000000012. Cancer J. 2014. PMID: 24445770 Review.
-
Emerging patent issues in genomic diagnostics.Nat Biotechnol. 2006 Aug;24(8):939-41. doi: 10.1038/nbt0806-939. Nat Biotechnol. 2006. PMID: 16900135 Review. No abstract available.